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Manuscript rece
accepted Novembeoronary computed tomography angiography (CTA) has emerged as a noninvasive method for direct visualization of
coronary artery disease, with previous studies demonstrating high diagnostic performance of CTA compared with
invasive coronary angiography. However, CTA assessment of coronary stenoses tends toward overestimation, and
even among CTA-identiﬁed severe stenosis conﬁrmed at the time of invasive coronary angiography, only a minority
are found to be ischemia causing. Recent advances in computational ﬂuid dynamics and image-based modeling
now permit determination of rest and hyperemic coronary ﬂow and pressure from CTA scans, without the need for
additional imaging, modiﬁcation of acquisition protocols, or administration of medications. These techniques have
been used to noninvasively compute fractional ﬂow reserve (FFR), which is the ratio of maximal coronary blood ﬂow
through a stenotic artery to the blood ﬂow in the hypothetical case that the artery was normal, using CTA images. In
the recently reported prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained
Via Noninvasive Fractional Flow Reserve) study and the DeFACTO (Determination of Fractional Flow Reserve by
Anatomic Computed Tomographic Angiography) trial, FFR derived from CTA was demonstrated as superior to
measures of CTA stenosis severity for determination of lesion-speciﬁc ischemia. Given the signiﬁcant interest in this
novel method for determining the physiological signiﬁcance of coronary artery disease, we herein present a review
on the scientiﬁc principles that underlie this technology. (J Am Coll Cardiol 2013;61:2233–41) ª 2013 by the
American College of Cardiology FoundationCoronary revascularization is often performed on an ad hoc
basis from semiquantitative measures of percent luminal
diameter narrowing of the artery visualized at the time of
invasive coronary angiography (ICA) (1). This practice
stems from the research of Gould et al. (2), who elegantly
demonstrated the relationship between stenosis and
ischemia, as determined by myocardial blood ﬂow reserve,
wherein ﬂow to the myocardium is compromised as the
luminal diameter progressively narrows. This diminution in
ﬂow is most evident at hyperemic states and begins as early
as 40% narrowing of vessel diameter, with more predictable
reductions in hyperemic ﬂow for stenoses 70% (3).
However, the relationship between coronary stenosis
and myocardial ischemia is more complex, with ensuing
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r 20, 2012.stenosis and ischemia (4). One example of this was high-
lighted in the nuclear substudy of the COURAGE (Clinical
Outcomes Utilizing Revascularization and Aggressive Drug
Evaluation) trial; in this study in patients with 70%
stenosis, only 32% exhibited severe ischemia and 40%
manifested no or mild ischemia according to myocardial
perfusion scintigraphy (5).
At present, the gold standard assessment of the hemo-
dynamic signiﬁcance of coronary stenoses is fractional ﬂow
reserve (FFR) (6). FFR uses a pressure wire to determine the
ratio of maximal coronary blood ﬂow through a stenotic
artery to the blood ﬂow in the hypothetical case that the
artery was normal, and it is the only diagnostic method to
date for ischemia detection to demonstrably advance event-
free survival (7,8). In the FAME (Fractional Flow Reserve
Versus Angiography for Multivessel Evaluation) trial of
1,005 patients with multivessel coronary artery disease
(CAD), FFR-guided revascularization (i.e, revascularization
for lesions with FFR 0.80) was associated with a 28%
lower rate of major adverse cardiac events compared with an
angiography-guided strategy. The salutary outcomes for
individuals undergoing FFR-guided revascularization are
long-lived and cost-saving (9). The results from FAME are
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2234in accordance with the 5-year
follow-up of individuals from the
DEFER (Deferral Versus Per-
formance of PTCA in Patients
Without Documented Ischemia)
study (7). Among lesions judg-
ed angiographically “obstructive,”
>50% were hemodynamically in-
signiﬁcant according to FFR. No
beneﬁt was observed for revascu-
larization in patients with hemo-
dynamically insigniﬁcant lesions.
In the FAME2 trial, FFR-guided
therapy reduced the need for ur-
gent revascularization in patients
with stable CAD and hemody-
namically signiﬁcant lesions (10).
Coronary computed tomog-
raphy angiography (CTA) is a
noninvasive method for visualiza-
tion of CAD (11–13). Previous
CTA studies have observed an
overestimation of stenosis severity,
and even among high-grade ste-
noses according to CTA con-ﬁrmed by using ICA, only a minority cause ischemia (14,15).
Coronary lesions considered severe according to CTA cause
ischemia less than one-half of the time (15). These ﬁndings
have provoked concerns that widespread application of CTA
may encourage unnecessary ICA (16).
Numerous imaging tests exist for physiological assess-
ment of CAD, including stress echocardiography, cardiac
magnetic resonance, and myocardial perfusion scintig-
raphy. These modalities assess wall motion abnormalities
or regional differences in coronary ﬂow reserve (CFR) as a
surrogate for ischemia and identify individuals who may
have severe stenoses. Although robust for ischemia
detection on a per-patient basis, these tests demonstrate
poor discrimination of speciﬁc vessels with coronary
lesions that cause ischemia. As an example, when using an
FFR standard for vessel-speciﬁc ischemia, myocardial
perfusion scintigraphy identiﬁes ischemic territories cor-
rectly <50% of the time, with underestimation and over-
estimation in 36% and 22% of cases, respectively (17).
Such data have evoked concerns for the ability of stress
testing to effectively isolate coronary lesions that beneﬁt
from revascularization.
Recent advances in computational ﬂuid dynamics enable
calculation of coronary ﬂow and pressure ﬁelds from
anatomic image data (18). Applied to CTA, these tech-
nologies enable calculation of FFR without additional
imaging or medications. The DISCOVER-FLOW (Diag-
nosis of Ischemia-Causing Stenoses Obtained Via Nonin-
vasive Fractional Flow Reserve) trial, compared with invasive
FFR, noninvasive FFR derived from CTA, or FFRCTA,
demonstrated per-vessel accuracy, sensitivity, speciﬁcity,positive predictive value (PPV), and negative predictive value
(NPV) for lesions causing ischemia of 84.3%, 87.9%, 82.2%,
73.9%, and 92.2%, respectively, for FFRCTA (19). The
performance of FFRCTA was superior to CTA stenosis for
diagnosing ischemic lesions, the latter of which demon-
strated an accuracy, sensitivity, speciﬁcity, PPV, and NPV of
58.5%, 91.4%, 39.6%, 46.5%, and 88.9%, respectively. Case
examples of non–ischemia-causing and ischemia-causing
stenoses can be seen in Figures 1 and 2, respectively.
More recently, the DeFACTO (Determination of Frac-
tional Flow Reserve by Anatomic Computed Tomographic
Angiography) trial, a pivotal multicenter international study
evaluating FFRCTA against CTA for diagnostic accuracy of
ischemia, has been published (20). This trial consisted of
252 patients for which 407 vessels were directly interrogated
by using FFR. On a per-patient basis, FFRCTA was superior
to CTA stenosis for diagnosis of ischemic lesions for accu-
racy (73% vs. 64%), sensitivity (90% vs. 84%), speciﬁcity
(54% vs. 42%), PPV (67% vs. 61%), and NPV (84% vs.
72%). In patients with intermediate stenoses (30% to 70%),
there was a more than 2-fold increase in sensitivity, from
37% to 82%, with no loss of speciﬁcity.
Given the rapid clinical evidence development of
FFRCTA, we herein present the fundamental tenets that
underlie the basis of computational modeling of coronary
ﬂow and pressure.
Cardiovascular Form and Function Relationships
Computation of FFRCTA requires construction of an
anatomic model of the coronary arteries; a mathematical
model of coronary physiology to derive boundary conditions
representing cardiac output, aortic pressure, and microcir-
culatory resistance; and a numerical solution of the laws of
physics governing ﬂuid dynamics. This combination of
anatomy, physiology, and ﬂuid dynamics enables the
computation of coronary ﬂow and pressure.
Anatomic data obtained from CTA contains a wealth of
information on coronary blood ﬂow because “form follows
function” in circulatory systems (21). These form–function
relationships are universal and enable the circulation to
provide an adequate supply of blood at appropriate pressures
to organs under varying physiological states (e.g., exercise)
and to adapt to chronic changes, including disease pro-
gression. Allometric scaling laws, which relate the mass of an
object to shape, anatomy, and physiology, are critical for
deﬁning cardiovascular form–function relationships and are
broadly applicable to the entire cardiovascular system (22).
Allometric scaling laws also enable relation of organ size to
ﬂow rate. For example, under resting conditions, total cor-
onary ﬂow is proportional to myocardial mass, Qc fMbmyo
(23). Mass can be calculated from myocardial volume, which
is easily extracted from volumetric CTA data.
Form–function relationships also apply directly to coronary
arteries, which may dilate or constrict to modulate organ
blood ﬂow (e.g., in exercise), enlarge in response to chronic
Figure 1 FFRCTA Results for 66-Year-Old Man With Multivessel CAD But No Lesion-Speciﬁc Ischemia
(A) Coronary computed tomography angiography (CTA) demonstrating stenosis in the left anterior descending coronary artery (LAD). (B) Fractional ﬂow reserve (FFR) derived from
CTA (FFRCTA) demonstrates no ischemia in the LAD, with a computed value of 0.91. (C) Invasive coronary angiography (ICA) with FFR also demonstrates no ischemia in the LAD,
with a measured value of 0.89. (D) CTA demonstrating stenosis in the left circumﬂex coronary (LCx) artery. (E) FFRCTA demonstrates no ischemia in the LCx, with a computed
value of 0.91. (F) ICA with FFR also demonstrates no ischemia in the LCx, with a measured value of 0.91.
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2235increases in blood ﬂow (e.g., in arteriovenous ﬁstulas), or
diminish in caliber in response to reductions in blood ﬂow.
The mathematical relationship between vessel size and ﬂow
rate was ﬁrst proposed by Murray (24) in 1926, as Qf dk,
where Q is the ﬂow rate through a blood vessel, d is its
diameter, and k is a constant derived empirically for which
Murray proposed a value of 3. In its simplest form, Murray’s
law is the manifestation of adaptive mechanisms whereby
blood vessels sense the level of shear stress on the endothelial
surface and remodel to maintain homeostasis. This ﬂow–
diameter relationship can be understood by considering
Poiseuille’s solution, which relates vessel ﬂow rate, Q, vessel
diameter, d, and the wall shear stress, sw, by the formula:
Q ¼ p
32m
swd3 [Equation 1]
where m is the ﬂuid viscosity. If wall shear stress is main-
tained at a constant, homeostatic level, then this formula
implies that Qf d 3, and Murray’s law is recovered.
Empirically, blood vessels have been proven to modulate
their size based on the ﬂow they carry and the wall shear
stress sensed by the endothelial cells (25). These adaptiveprocesses typically complete in a few weeks (4 to 6 weeks)
(26) and continue even in the presence of atherosclerosis
(27). Consequently, a coronary vessel that subtends a myo-
cardial territory with lower perfusion will diminish in caliber,
whereas chronic increases in blood ﬂow, as might be
observed subsequent to revascularization of a coronary
stenosis or after initiation of an exercise regimen, will result
in luminal enlargement.
Morphometry laws of the form Qf dk provide additional
physiological information for assessing the relative resistance
to ﬂow of branches arising from the coronary arteries. Under
resting conditions, the mean pressure, p, down the length of
a coronary artery is largely constant and forces ﬂow through
each branch in accordance with the relationship:
p ¼ QR [Equation 2]
where R is the resistance to ﬂow of the branch vessel.
Therefore, Qf dk implies that R f dk, or that the resis-
tance to ﬂow of each branch is inversely related to vessel size,
with the same morphometric exponent, k, relating ﬂow to
diameter. Thus, small coronary branches have a higher
resistance to ﬂow than larger branches, and the resistance to
Figure 2 FFRCTA Results for 66-Year-Old Man With Multivessel CAD and Lesion-Speciﬁc Ischemia
(A) CTA demonstrating stenosis in the LAD. (B) FFRCTA demonstrates ischemia in the LAD, with a computed value of 0.64. (C) ICA with FFR also demonstrates ischemia in the
LAD, with a measured value of 0.72. (D) CTA demonstrating stenosis in the LCx. (E) FFRCTA demonstrates ischemia in the LCx, with a computed value of 0.61. (F) ICA with FFR
also demonstrates ischemia in the LCx, with a measured value of 0.52. Abbreviations as in Figure 1.
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2236ﬂow distal to a stenosis will be directly related to the number
and size of vessels downstream.
Computational Fluid Dynamics
Coronary ﬂow and pressure can be computed by solving the
governing equations of ﬂuid dynamics, which relate to
conservation of mass and balance of momentum, and which
have been known in their current forms as the Navier-
Stokes equations for >150 years. These equations are
solved for the unknown pressure, which varies with position
and time, and for the 3 components of blood velocity, each
of which are functions of position and time. The physical
properties of blood, the ﬂuid density and the ﬂuid viscosity,
are known when solving these equations. Although blood
exhibits complex rheological properties, it can be approxi-
mated as a Newtonian ﬂuid with a constant viscosity in large
arteries.
Notable features of the equations of ﬂuid dynamics are
their universality for describing phenomena ranging from
airﬂow over a jetliner to water ﬂow in a river to blood ﬂow in
arteries, as well as their ability to capture complex phe-
nomena. However, the governing equations of blood ﬂow can
only be solved analytically under special circumstances (e.g.,
steady or pulsatile ﬂow in an idealized circular cylindricalgeometry). For realistic patient-speciﬁc models of the human
coronary arteries, a numerical method must instead be used to
approximate the governing equations and to obtain a solution
for velocity and pressure at a ﬁnite number of points (28).
This requires solving millions of nonlinear partial differential
equations simultaneously and repeating this process for
thousands of time intervals in a cardiac cycle. Numerical
methods for solving ﬂuid dynamics problems are known as
computational ﬂuid dynamics (CFD) methods.
The governing equations are insufﬁcient to solve blood
ﬂow problems; a domain of interest must be deﬁned, and
boundary conditions need to be speciﬁed. Boundary condi-
tions are mathematical relationships between the variables of
interest (e.g., ﬂow and pressure) deﬁned on the boundaries of
the mathematical model. Speciﬁc to modeling blood ﬂow in
arteries, the domain of interest is where the blood is ﬂowing
(i.e., the lumen), and the relevant boundaries are the lateral
surface, the inlet boundary (the aortic root), and the outlet
boundaries of the ascending aorta and the coronary arteries.
It is virtually impossible to directly represent the heart
and the >5 billion blood vessels in the human circulation,
so the domain of interest for CFD models of arterial blood
ﬂow is a deﬁned portion of the vascular system. Conse-
quently, it is necessary to describe the conditions at the
interface of the modeled domain and the remainder of the
Figure 3
Mathematical Model of Blood Flow Through an Idealized LAD Stenosis With a Reference Diameter of 3.5 mm
and a 60% Diameter Reduction Stenosis
A constant pressure (Pa ¼ 90 mm Hg) is applied at the inlet boundary, and a constant resistance, Rmicro, is prescribed at the outlet boundary to simulate the downstream
microcirculatory resistance. The velocity is set at zero along the luminal boundary. Rmicro is set at 120,000 dynes$s/cm
2 to model baseline conditions with a ﬂow rate of 1 cc/s
and is reduced by a factor of 4.5 to 26,664.4 dynes$s/cm2 to model hyperemic conditions. Hyperemic ﬂow increases to 3.6 cc/s. The velocity on a slice along the vessel
illustrates that a jet through the stenosis rapidly dissipates under baseline conditions but persists under hyperemic conditions. (Pd/Pa ¼ 0.97 at baseline, FFR ¼ Pd/Pa ¼ 0.79
at hyperemia). Abbreviations as in Figure 1.
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2237circulation. Figure 3 illustrates these concepts in an idealized
model of steady ﬂow through a single coronary artery with
a stenosis.
Image-Based Modeling of Blood Flow in Arteries
Coupled to CFD, the computation of FFR from CTA
requires methods to extract models from image data and to
incorporate boundary conditions that demonstrate the effect
of the microcirculation (28,29). One contemporary devel-
opment in image-based modeling of blood ﬂow enablesFigure 4 Image Segmentation Steps for Computing FFRCTA
From left, volume-rendered image, lumen boundary surface segmented from image data,modeling of pulsatile coronary ﬂow and pressure in realistic
patient-speciﬁc models (18). Figure 4 depicts steps in the
creation of an anatomic model of the coronary lumen from
CTA data. During the model construction process, image
segmentation algorithms extract the luminal surface of the
major vessels and branches, up to the limits imposed by the
resolution of CTA. This segmentation process involves
extracting the topology of the coronary artery tree; identi-
fying, analyzing, and segmenting coronary plaques in each
vessel; and extracting the luminal boundary. For the ﬁnite
element method used in the FFRCTA technology, a mesh isand ﬁnal 3-dimensional model. Abbreviation as in Figure 1.
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2238generated from the geometric model with millions of
vertices and elements, and solved for velocity and pressure
on a parallel supercomputer.
FFR Derived From CTA
Noninvasive computation of FFR requires coupling lumped
parameter models of the heart, systemic circulation, and
coronary microcirculation to a patient-speciﬁc model of the
aortic root and epicardial coronary arteries extracted fromFigure 5 Mathematical Model for Pulsatile Coronary Flow
(A) Lumped parameter models are coupled to the aortic inlet and noncoronary vasculatu
capacitance, L the inductance, and E(t) the elastance. Subscript LA is for the left atrium, AV
im for intermyocardial, and V for venous. (B) Pulsatile pressure and ﬂow rate waveforms d
followed by increased ﬂow in diastole resulting from relaxation of the ventricle. (C) Three-
Note the pressure gradients and high-velocity jets across stenoses in the LAD, LCx, andCTA data. As shown in Figure 5, at the aortic inlet,
a lumped parameter model representing the left ventricle is
coupled to the aorta (18). At the aortic outlet, the model is
used to enforce a relationship between pressure and ﬂow
(e.g., the aortic impedance). Notably, the cardiac output and
the aortic pressure arise naturally through the interaction of
the heart model and the model of the systemic circulation.
For computation of FFR, parameters in the lumped models
of the heart and systemic circulation are chosen so that the
computed cardiac output matches that computed from anre and coronary microcirculation (18). P is the pressure, R the resistance, C the
for atrioventricular, V-Art for ventricle-arterial, p for proximal, d for distal, a for arterial,
emonstrate reduced coronary ﬂow in early systole due to contraction of the ventricle
dimensional pressure and velocity ﬁelds are computed throughout the cardiac cycle.
right coronary artery (RCA). Abbreviations as in Figure 1.
Figure 6
FFRCTA Result for Patient With Serial Lesions
in the LAD
Color contours provide data on the distribution of FFRCTA throughout the coronary
tree, and numerical values can be obtained at any location. Abbreviations as in
Figure 1.
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2239allometric scaling law, and the computed mean aortic pres-
sure matches the patient’s measured mean brachial pressure.
At the coronary outlets, a relationship between pressure and
ﬂow based on a model of the coronary microcirculation is
enforced.Figure 7 Comparison of FFRCTA Results Before and After Simulated
(A) Before and (B) after percutaneous coronary intervention (PCI). FFRCTA values are supA key step in assignment of coronary outlet boundary
conditions for computation of FFRCTA is the prescription of
unique resistance values for each outlet, based on the
morphometry laws relating form and function described
previously. Speciﬁcally, total coronary ﬂow under basal
conditions is computed from the myocardial wall volume
extracted from CTA. Next, total coronary resistance is
calculated from total coronary ﬂow, and the mean aortic
pressure is estimated from the mean brachial artery pressure.
The basal resistance of each individual coronary outlet
boundary is then computed by using total coronary resis-
tance and a morphometry law of the form R f dk,
inversely relating the resistance to ﬂow of each branch to
vessel diameter. Finally, for the lateral surface boundaries,
a zero velocity (i.e., a “no-slip condition” for viscous ﬂuids) is
applied.
The ﬁnal step in assigning boundary conditions is simu-
lating maximum hyperemia by modeling the effect of
adenosine on reducing the peripheral resistance of the
coronary microcirculation downstream of the epicardial
arteries extracted from CTA. Wilson et al. (30) showed that
for arteries with normal CFR, in which the epicardial
resistance would be expected to be small both at rest and
during hyperemia, total coronary resistance at maximum
hyperemia fell to 0.24 of the resting value with intravenous
administration of adenosine 140 mg/kg/min. This dose
underlies that which is administered for pharmacological
stress testing and is the dose used for measurement of FFR.
This change in resistance of normal coronary arteries
provides an upper bound on the maximal change that can be
achieved in patients with microcirculatory dysfunction andPCI With Stent Implantation
erposed on images of particle trajectories. Abbreviation as in Figure 1.
Figure 8 Application of FFRCTA Technology to Predict Hemodynamic Changes Due to CABG
(A) Pre-intervention FFRCTA demonstrates signiﬁcant disease in RCA and LCx, including left main artery and RCA ostial lesions. (B) Post-coronary artery bypass graft (CABG)
FFRCTA demonstrates marked reduction in vessel ischemia resulting from saphenous vein grafts (SVG) but little change in the LAD from the left internal mammary artery (LIMA).
(C) Time-averaged blood velocity is shown in native vessels and bypass grafts. Abbreviations as in Figures 1 and 5.
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2240represents an assumption made with invasive FFR, wherein
the hyperemic microcirculatory resistance distal to a stenosis
is assumed to be the same as that in the hypothetical case
that the coronary arteries have no disease (31).
Upon generation of a discrete model (e.g., ﬁnite element
mesh) of the ascending aorta and epicardial coronary arteries,
and the deﬁnition of the boundary conditions for rest and
hyperemic conditions, FFRCTA can then be determined by
solving the equations of blood ﬂow for the velocity and
pressure ﬁelds. FFRCTA is then obtained by normalizing the
mean hyperemic pressure ﬁeld by the average mean hyper-
emic pressure in the aorta. The end result is a complete spatial
distribution of FFRCTA, as shown in Figure 6 for a patient
with signiﬁcant ischemia resulting from serial lesions in the
left anterior descending coronary artery.Limitations
Numerous artifacts may affect CTA interpretability,
including calciﬁcation, motion, and misregistration. Because
FFRCTA requires accurate anatomic models, these artifacts
may limit accuracy. Thus, adherence to protocols that
ensure good quality data and facilitate accurate lumen
boundary descriptions is essential (32). Additional limita-
tions of FFRCTA relate to assumptions in the physiological
models that include population-speciﬁc as well as patient-
speciﬁc data. Relationships relating myocardial mass to
total coronary ﬂow, the relative coronary microvascular
resistance based on vessel size, or reductions in resistance in
response to adenosine-mediated hyperemia will vary among
patients. In patients with microvascular disease, models of
adenosine-mediated hyperemia may overestimate the degree
of vasodilation, resulting in FFRCTA values below those of
measured FFR. Finally, no published data exist for FFRCTA
in the evaluation of in-stent restenosis or for coronary artery
bypass grafts.Future Possibilities
CFD methods applied to CTA data have enabled nonin-
vasive assessment of lesion-speciﬁc ischemia by FFRCTA.
Importantly, these methods may also enable prediction of
changes in coronary ﬂow and pressure from therapeutic
interventions (e.g., percutaneous coronary intervention,
coronary artery bypass graft) as shown in Figures 7 and 8.
FFRCTA enables study of other hemodynamic metrics (e.g.,
CFR, shear stress, total plaque force). For example, com-
puted blood velocity, as shown in Figure 8C, may allow
evaluation of ﬂow stagnation in bypass grafts. In addition,
other physiological states such as graded exercise conditions
can be modeled. Finally, the technology underlying FFRCTA
is applicable to other common cardiovascular conditions,
including peripheral, cerebrovascular, and renovascular
disease, and may be used to determine whether vascular
stenoses are hemodynamically signiﬁcant as well as the
relative beneﬁt of therapeutic interventions.Reprint requests and correspondence: Dr. James K. Min,
Cedars-Sinai Medical Center, Cardiology, The Heart Institute,
8700 Beverly Boulevard, Taper Building, Room 1253, Los
Angeles, California 90048. E-mail: james.min@cshs.org.REFERENCES
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